XT
CGTX icon

XTX Topco’s Cognition Therapeutics CGTX Stock Holding History

XTX Topco’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.2K Sell
78,471
-117,332
-60% -$139K ﹤0.01% 3560
2026
Q1 		$149K Buy
195,803
+158,576
+426% +$185K ﹤0.01% 2958
2025
Q4 		$50.3K Buy
+37,227
New +$60.4K ﹤0.01% 2833
2025
Q3 		– Sell
-16,603
Closed -$5.14K – 2645
2025
Q2 		$5.14K Buy
+16,603
New +$5.61K ﹤0.01% 2256

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

XTX Topco's CGTX Position: Q2 2026 in Review

XTX Topco reduced its Cognition Therapeutics (CGTX) stake by 60% in Q2 2026, selling an estimated $139K and leaving 78,471 shares worth $90.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3560.

XTX Topco first reported a position in CGTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $149K in Q1 2026. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • XTX Topco held 78,471 shares of Cognition Therapeutics worth $90.2K as of Q2 2026.
  • XTX Topco sold 117,332 Cognition Therapeutics shares in Q2 2026, an estimated $139K.
  • Cognition Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3560 holding.
  • XTX Topco first reported a position in Cognition Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • XTX Topco's Cognition Therapeutics position peaked at $149K in Q1 2026.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.